OBJECTIVE: To assess the efficacy of @entity7855 as a first-step diagnostic and therapeutic tool for @entity323 ( @entity323 ) and to evaluate the consequent changes in the management of male @entity458 . MATERIALS AND METHODS: @entity7855 in titrating doses up to 100 mg was prescribed to 50 @entity1 presenting to a @entity250 clinic with medically documented @entity323 . They had not undergone any specific diagnostic test before starting @entity7855 . RESULTS: Of the 50 @entity1 , 24 (48%) responded to @entity7855 . Of these, 8 (33.3%) responded to 50 mg and 16 (66.7%) to 100 mg of @entity7855 . Of the responders, 9 representing 18% of all studied @entity1 were discharged achieving spontaneous erections in a mean follow-up of 5.3 months. @entity1 with no medical history, @entity1 with @entity101 and @entity1 with mild @entity453 responded better. CONCLUSIONS: The @entity7855 test revealed that 48% of @entity1 responded to this therapy with no requirement for more invasive tests and that 18% of @entity1 required no further treatment at all. In addition this test reduced the overall cost of the diagnostic investigation. It is proposed that the @entity7855 test should be used in cases with no significant medical history or in @entity1 with @entity101 or mild @entity453 although almost all @entity1 with @entity323 could be categorized as @entity7855 -responders or @entity7855 -resistant. It is also suggested that the @entity7855 test would result in the ability for more @entity1 with @entity323 to be managed exclusively in the primary care sector.

XXXX test: changes in the diagnostic and therapeutic management of @entity323 .

@entity1 :: ('9606', 'Species') :: ['men', 'Men'] @entity323 :: ('MESH:D007172', 'Disease') :: ['erectile dysfunction', 'ED'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity458 :: ('MESH:D020018', 'Disease') :: ['sexual insufficiency'] @entity7855 :: ('MESH:C101426', 'Chemical') :: ['sildenafil', 'Sildenafil'] @entity453 :: ('MESH:D003324', 'Disease') :: ['coronary artery disease'] @entity250 :: ('MESH:D012735', 'Disease') :: ['sexual dysfunction']
@entity7855 :: (MESH:C101426,Chemical) :: ['Sildenafil']
